Evidence map›Paper›PMID 33093691›Full record

ReviewThe Ulster medical journal2020

Masked Hypertension: Lessons for the Future.

Krishnam R Penmatsa, Mohan Biyani, Ankur Gupta

Abstract readReview
In one paragraph

Review in The Ulster medical journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Masked hypertension in patients with irritable bowel syndrome.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Krishnam R PenmatsaKrishnam R. Penmatsa: MD, DM: Consultant Nephrology, Indus Hospital, Vishakhapatnam, India.
Mohan BiyaniKrishnam R. Penmatsa: MD, DM: Consultant Nephrology, Indus Hospital, Vishakhapatnam, India.
Ankur GuptaKrishnam R. Penmatsa: MD, DM: Consultant Nephrology, Indus Hospital, Vishakhapatnam, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Masked hypertension (MH) is a commonly overlooked phenotype of hypertension in practice. Lifestyle factors and conditioned stress response specific to out of clinic blood pressure readings may be the mechanisms leading to this phenomenon. 24-hour ambulatory blood pressure monitoring or home blood pressure monitoring in an out of office setting are required for its reliable diagnosis. MH has a high risk of progressing to sustained hypertension with comparable cardiovascular and mortality risk. In this review, we discuss current evidence-based perspectives on definition, pathological mechanisms, risk factors, screening, clinical implications, and treatment of MH.

Indexed as

Masked HypertensionAntihypertensive AgentsBlood Pressure DeterminationHumansAntihypertensive AgentsclassificationMasked hypertensionmechanismsoutcomes

Identifiers

PMID33093691
PMCPMC7576393

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.